Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14102139
Abstract: The family of nuclear peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, and PPARγ) is a set of ligand-activated transcription factors that regulate different functions in the body. Whereas activation of PPARα is known to reduce the levels… read more here.
Keywords: ppar; heterocyclic ppar; ppar ligands; development heterocyclic ... See more keywords